CDK7-IN-6
Modify Date: 2025-08-27 13:00:44
CDK7-IN-6 structure
|
Common Name | CDK7-IN-6 | ||
|---|---|---|---|---|
| CAS Number | 2378710-04-2 | Molecular Weight | 524.06 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H34ClN9O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CDK7-IN-6CDK7-IN-6 is a potent and selective cyclin-dependent kinase (CDK7) inhibitor (IC50≤100 nM), extracted from patent WO2019197549 A1, compound 210. CDK7-IN-6 is > 200-fold selective for CDK7 over CDK1, CDK2, and CDK5. CDK7-IN-6 can be used for the research of cancer[1]. |
| Name | CDK7-IN-6 |
|---|
| Description | CDK7-IN-6 is a potent and selective cyclin-dependent kinase (CDK7) inhibitor (IC50≤100 nM), extracted from patent WO2019197549 A1, compound 210. CDK7-IN-6 is > 200-fold selective for CDK7 over CDK1, CDK2, and CDK5. CDK7-IN-6 can be used for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
CDK7:≤100 nM (IC50) |
| In Vitro | CDK7-IN-6 inhibits the viability of HCT116, H460, MV4-11, A2780, and OVCAR cells (IC50≤1 μM)[1]. |
| References |
| Molecular Formula | C26H34ClN9O |
|---|---|
| Molecular Weight | 524.06 |